Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - TOTAL EQUITY
Total Equity ABUS - Arbutus Biopharma Corporation
106 M
LAST VALUE
-20.90%
2 YEAR CAGR
-11.94%
5 YEAR CAGR
6.00%
10 YEAR CAGR